Trial Profile
Sofosbuvir, Simeprevir, +/- Ribavirin in HCV Protease Inhibitor-Experienced Patients.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 25 Aug 2015
Price :
$35
*
At a glance
- Drugs Ribavirin (Primary) ; Simeprevir (Primary) ; Sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 25 Aug 2015 New trial record